Intrexon Corporation (NYSE: XON) announced today the closing of its previously announced underwritten public offering of common stock. Intrexon sold 6,900,000 shares of its common stock at a public offering price of $12.50 per share, including the exercise in full by the underwriters of their option to purchase an additional 900,000 shares of common stock. Gross proceeds to Intrexon from the offering are expected to be approximately $86 million before deducting the underwriting discount and other offering expenses payable by Intrexon.
JMP Securities LLC acted as sole book-running manager and Stifel acted as lead manager for the offering. Northland Capital Markets acted as co-manager for the offering.
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.